Alvimedica to build $370M manufacturing plant in Turkey

Turkish interventional cardiology firm Alvimedica plans to invest around $370 million to build a new manufacturing plant in Turkey, its third, to meet demand for its Cre8 drug-eluting stents and balloons. The investment will be supported by Turkish government incentives.

“Alvimedica is pumping around $370m into the construction of a new manufacturing plant in Turkey – its third to date – to meet what it believes will be increasing demand for its Cre8 family drug-eluting stents and balloons.”insights.citeline.com

• 1 source
• insights.citeline.comTurkey's Alvimedica Ramps Up Global Expansion In Interventional CardioAhmet SevindikMay 17, 2018

Summarized from public sources; check the original articles before acting on it.